Skip to main content
Jason Thonhoff, MD, Neurology, Houston, TX, Houston Methodist Hospital

JasonRobertThonhoffMDPhD

Neurology Houston, TX

Neuromuscular Medicine

Physician

Dr. Thonhoff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Thonhoff's full profile

Already have an account?

Summary

  • Dr. Jason Thonhoff is a neurologist in Houston, TX and is affiliated with Houston Methodist Hospital. He received his medical degree from the University of Texas Medical Branch and has been in practice 9 years. He specializes in neuromuscular medicine and is experienced in amyotrophic lateral sclerosis and muscular dystrophy. He has more than 20 publications and over 500 citings.

Education & Training

  • Methodist Hospital (Houston)
    Methodist Hospital (Houston)Residency, Neurology, 2011 - 2015
  • University of Texas Medical Branch School of Medicine
    University of Texas Medical Branch School of MedicineClass of 2011

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2015 - 2025
  • American Board of Psychiatry and Neurology Neurology
  • American Board of Psychiatry and Neurology Neuromuscular Medicine

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Coya Therapeutics, Inc. Announces Positive Results from a Proof-of-Concept Academic Clinical Study for COYA 302 in Amyotrophic Lateral Sclerosis (ALS)
    Coya Therapeutics, Inc. Announces Positive Results from a Proof-of-Concept Academic Clinical Study for COYA 302 in Amyotrophic Lateral Sclerosis (ALS)March 21st, 2023
  • ALS Patients' Own Cells May Provide a Safe Pathway to Slow or Halt Progression
    ALS Patients' Own Cells May Provide a Safe Pathway to Slow or Halt ProgressionOctober 7th, 2022
  • When Spinal Fluid from ALS Patients Was Put into Mice, the Mice Got Weak. An Unlikely Protein Could Be the Culprit
    When Spinal Fluid from ALS Patients Was Put into Mice, the Mice Got Weak. An Unlikely Protein Could Be the CulpritAugust 22nd, 2022
  • Join now to see all

Grant Support

  • Combined Stem Cell And Anti-Oxidative Therapy For ALSNational Institute Of Neurological Disorders And Stroke2007–2010

Hospital Affiliations